Literature DB >> 23714164

First screening of Aedes albopictus immunogenic salivary proteins.

S Doucoure1, S Cornelie, S Patramool, F Mouchet, E Demettre, M Seveno, J S Dehecq, H Rutee, J P Herve, F Favier, D Missé, P Gasque, F Remoue.   

Abstract

Study of the human antibody (Ab) response to Aedes salivary proteins can provide new biomarkers to evaluate human exposure to vector bites. The identification of genus- and/or species-specific proteins is necessary to improve the accuracy of biomarkers. We analysed Aedes albopictus immunogenic salivary proteins by 2D immunoproteomic technology and compared the profiles according to human individual exposure to Ae. albopictus or Ae. aegypti bites. Strong antigenicity to Ae. albopictus salivary proteins was detected in all individuals whatever the nature of Aedes exposure. Amongst these antigenic proteins, 68% are involved in blood feeding, including D7 protein family, adenosine deaminase, serpin and apyrase. This study provides an insight into the repertoire of Ae. albopictus immunogenic salivary proteins for the first time.
© 2013 Royal Entomological Society.

Entities:  

Keywords:  Ae. albopictus; biomarker; exposure; immunogenic; saliva

Mesh:

Substances:

Year:  2013        PMID: 23714164     DOI: 10.1111/imb.12032

Source DB:  PubMed          Journal:  Insect Mol Biol        ISSN: 0962-1075            Impact factor:   3.585


  8 in total

1.  Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.

Authors:  Emmanuel Elanga Ndille; Souleymane Doucoure; Anne Poinsignon; François Mouchet; Sylvie Cornelie; Eric D'Ortenzio; Jean Sébastien DeHecq; Franck Remoue
Journal:  PLoS Negl Trop Dis       Date:  2016-12-01

2.  MicroRNAs from saliva of anopheline mosquitoes mimic human endogenous miRNAs and may contribute to vector-host-pathogen interactions.

Authors:  Bruno Arcà; Alessio Colantoni; Carmine Fiorillo; Francesco Severini; Vladimir Benes; Marco Di Luca; Raffaele A Calogero; Fabrizio Lombardo
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

3.  Analysis in a murine model points to IgG responses against the 34k2 salivary proteins from Aedes albopictus and Aedes aegypti as novel promising candidate markers of host exposure to Aedes mosquitoes.

Authors:  Sara Buezo Montero; Paolo Gabrieli; Francesco Severini; Leonardo Picci; Marco Di Luca; Federico Forneris; Luca Facchinelli; Marta Ponzi; Fabrizio Lombardo; Bruno Arcà
Journal:  PLoS Negl Trop Dis       Date:  2019-10-16

4.  Multiple Salivary Proteins from Aedes aegypti Mosquito Bind to the Zika Virus Envelope Protein.

Authors:  Paola Carolina Valenzuela-Leon; Gaurav Shrivastava; Ines Martin-Martin; Jenny C Cardenas; Berlin Londono-Renteria; Eric Calvo
Journal:  Viruses       Date:  2022-01-24       Impact factor: 5.048

5.  Aedes albopictus salivary proteins adenosine deaminase and 34k2 interact with human mast cell specific proteases tryptase and chymase.

Authors:  Zhiqiang Li; Cejuan Ji; Jinzhi Cheng; Magnus Åbrink; Tao Shen; Xiaoyuan Kuang; Zhengling Shang; Jiahong Wu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  Serosurvey of Human Antibodies Recognizing Aedes aegypti D7 Salivary Proteins in Colombia.

Authors:  Berlin L Londono-Renteria; Heman Shakeri; Paula Rozo-Lopez; Michael J Conway; Natasha Duggan; Majid Jaberi-Douraki; Tonya M Colpitts
Journal:  Front Public Health       Date:  2018-05-18

Review 7.  New Immuno-Epidemiological Biomarker of Human Exposure to Aedes Vector Bites: From Concept to Applications.

Authors:  André B Sagna; Mabo C Yobo; Emmanuel Elanga Ndille; Franck Remoue
Journal:  Trop Med Infect Dis       Date:  2018-08-01

8.  Aedes albopictus D7 Salivary Protein Prevents Host Hemostasis and Inflammation.

Authors:  Ines Martin-Martin; Leticia Barion Smith; Andrezza Campos Chagas; Anderson Sá-Nunes; Gaurav Shrivastava; Paola Carolina Valenzuela-Leon; Eric Calvo
Journal:  Biomolecules       Date:  2020-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.